Crataegus crenulata Roxb.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Rosaceae. |
| Habitat | The Himalayas from Sutluj to Bhutan at altitudes of 800– 2,500 m. |
| Folk | Ghingaaru. |
| Action | See Cratageus oxyacantha. |
| Taxonomic Cohort | Genus Crataegus (1 documented species); Family Rosaceae (36 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Crataegus crenulata (taxonomically cited with authority Roxb.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Rosaceae (primary family classification: Rosaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: The Himalayas from Sutluj to Bhutan at altitudes of 800– 2,500 m.
Across classical and vernacular Indian systems of medicine, Crataegus crenulata is recognized under distinct polyglot nomenclature: in regional Indian folk and vernacular ethnobotany as Ghingaaru. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Crataegus crenulata are: See Cratageus oxyacantha. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
The therapeutic activity of Crataegus crenulata is grounded in its documented pharmacological actions (See Cratageus oxyacantha) and the characteristic secondary metabolite profile of the family Rosaceae.

Botanical Reference 1: Pyracantha crenulata — Botanical specimen

Botanical Reference 2: Pyracantha crenulata — Botanical specimen

Botanical Reference 3: Crataegus crenulata — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Within Indian medicinal flora, Crataegus crenulata stands as a distinct representative of the genus Crataegus. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.
At the family level, Rosaceae encompasses 36 documented medicinal species (1.98% of the 1,814-species flora). Other representative medicinal members of Rosaceae include: Amygdalus communis (Vaataama), Amygdalus persica (Aaruka), Brayera anthelmintica (Cusso), Crataegeus oxyacantha (English Hawthorn), Cydonia oblonga (Amritaphala). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 36 medicinal species of family Rosaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Crataegus crenulata follow the plant-part modalities specified under its therapeutic action (See Cratageus oxyacantha), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Crataegus crenulata integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.